Use App
Trending
News
Earnings
All
DIA
0.81%
SPY
0.71%
QQQ
0.85%
Trending
MU
3.60%
RIVN
1.35%
VG
0.74%
GLD
4.95%
DJT
6.02%
LNG
6.94%
GOAI
17.29%
TMC
5.89%
LUNR
1.49%
VET
15.62%
MU
3.60%
RIVN
1.35%
VG
0.74%
GLD
4.95%
DJT
6.02%
LNG
6.94%
GOAI
17.29%
TMC
5.89%
LUNR
1.49%
VET
15.62%
home
Symbol
CNSP
news
CNSP
Cns Pharmaceuticals Inc
7,783
Mkt Cap
$1.36M
Volume
11,647.00
52W High
$46.42
52W Low
$2.06
PE Ratio
-0.04
CNSP Fundamentals
Price
$2.28
Prev Close
$2.20
Open
$2.24
50D MA
$4.40
Beta
1.03
Avg. Volume
20,952.13
EPS (Annual)
-$466.44
P/B
0.13
Rev/Employee
$0.00
$3.83
PE Ratio
-0.04
Loading...
Loading...
Feed
News
Sentiment
Fundamentals
Info
News
all
press releases
CNS Pharmaceuticals Stock Declines On Wider Q1 Loss: But Retail Stays Unmoved
The company intends to commence the phase 2 study of its lead program, TPI 287, to treat Glioblastoma Multiforme (GBM) by year-end.
Stocktwits
·
10mo ago
Full Article
<
...
1
>
Latest CNSP News
View
Advertisement
|
Remove ads.
Top Discussions
top
active
trending
Advertisement
|
Remove ads.
Advertisement
|
Remove ads.
Watchlist
Trending
News
Explore
Community
Profile